|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Cash flows from operating activities | |||
| Net increase (decrease) in net assets resulting from operations | |||
| Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities: | |||
| Net change in unrealized (appreciation) depreciation from investments | |||
| Net (accretion of discounts) and amortization of premiums | |||
| Purchase of investments | |||
| PIK interest capitalized | |||
| Proceeds from sales of investments and principal repayments | |||
| Amortization of deferred financing costs | |||
| Net realized (gain) loss from investments | |||
| (Increase) Decrease in operating assets: | |||
| Interest receivable | |||
| Other assets | |||
| Prepaid expenses | |||
| Deferred offering costs | |||
| Receivable for investment sold | |||
| Due from affiliates | |||
| Prepaid expenses and other assets | |||
| Increase (Decrease) in operating liabilities: | |||
| Legal fees payable | |||
| Valuation fees payables | |||
| Administrator fees payable | |||
| Audit fees payable | |||
| Director fees payable | |||
| Income-based incentive fees payable | |||
| Management fee payable | |||
| Capital gains incentive fees payable | |||
| Professional fees payable | |||
| Transaction fees payable related to the Loan Portfolio Acquisition | |||
| Other payables | |||
| Due to affiliates | |||
| Excise tax payable | |||
| Offering cost payable | |||
| Organizational costs payable | |||
| Unearned interest income | |||
| Net cash provided by (used in) operating activities | |||
| Cash flows from financing activities | |||
| Offering costs paid | |||
| Distributions paid | |||
| Financing costs paid | |||
| Proceeds from borrowings on revolving line of credit | |||
| Principal payments under revolving line of credit | |||
| Proceeds from issuance of common stock | |||
| Net cash provided by (used in) financing activities | |||
| Net increase (decrease) in cash and cash equivalents | |||
| Cash and cash equivalents, beginning of period | |||
| Cash and cash equivalents, end of period | |||
| Supplemental disclosures | |||
| Excise taxes paid | |||
| Interest expense paid | |||
| Non-cash operating, financing and investing activity | |||
| Reinvestment of dividend distributions | |||
| Accrual for deferred financing costs (Note 2) | |||
| Accrual for deferred offering costs (Note 2) | |||
| Reinvestment of dividend distribution | |||
| Loans acquired for issuances of shares of common stock |
Loading...